510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K950169Substantially Equivalent

Ribosomal P Eia Test System

Hogan & Hartson, Washington, D.C. DC / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K950169 is the FDA 510(k) clearance record for RIBOSOMAL P EIA TEST SYSTEM, a class II device, cleared for Hogan & Hartson on under FDA product code MQA (Anti-Ribosomal P Antibodies). FDA records list 26 510(k) clearances for Hogan & Hartson, from to . As of , FDA records show no recalls naming K950169.

Clearance record

Decision date
Received
(492 days to decision)
Product code
MQA Anti-Ribosomal P Antibodies
Regulation
21 CFR 866.5100
Device class
Class II
Review panel
Immunology
Applicant
Hogan & Hartson Columbia Sq., Washington, D.C. DC
510(k) summary
Summary
Third party review
No

Clearances, product code MQA

Trailing 12 months

FDA records hold no clearances under product code MQA in the trailing twelve months.

FDA records show no clearances under product code MQA in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code MQA, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260